Kura Oncology (KURA) Misses Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Join SI Premium – FREE
Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.85), $0.10 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $20.75 million versus the consensus estimate of $20.66 million.
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bank Of Marin Bancorp (BMRC) Tops Q3 EPS by 5c
- CEMEX, S.A.B. de C.V. (CX) Tops Q3 EPS by 4c
- Evercore Previews Amazon (AMZN) Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
